Abstract
Chronic prostatitis was the most common type of prostatitis and oxidative stress was reported to be highly elevated in prostatitis patients. In this study, we determined the effect of N-acetylcysteine (NAC) on prostatitis and the molecular mechanism involved in it. Male Sprague-Dawley rats were divided into three groups: control group (group A, n = 20), carrageenan-induced chronic nonbacterial prostatitis (CNP) model group (group B, n = 20), and carrageenan-induced CNP model group with NAC injection (group C, n = 20). Eye score, locomotion score, inflammatory cell count, cyclooxygenase 2 (COX2) expression, and Evans blue were compared in these three groups. The expression of miR-141 was determined by quantitative real-time PCR (qRT-PCR). Moreover, protein expressions of Kelch-like ECH-associated protein-1 (Keap1) and nuclear factor erythroid-2 related factor 2 (Nrf2) and its target genes were examined by Western blot. Luciferase reporter assay was performed in RWPE-1 cells transfected miR-141 mimic or inhibitor and the plasmid carrying 3′-UTR of Keap1. The value of eye score, locomotion score, inflammatory cell count, and Evans blue were significantly decreased in group C, as well as the expression of COX2, when comparing to that of group B. These results indicated that NAC relieved the carrageenan-induced CNP. Further, we found that NAC increased the expression of miR-141 and activated the Keap1/Nrf2 signaling. Luciferase reporter assay revealed that miR-141 mimic could suppress the activity of Keap1 and stimulate the downstream target genes of Nrf2. In addition, miR-141 inhibitor could reduce the effect of NAC on prostatitis. NAC ameliorates the carrageenan-induced prostatitis and prostate inflammation pain through miR-141 regulating Keap1/Nrf2 signaling.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Clemens, J.Q., et al. 2009. Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. Urology 74(5): 983–987.e3.
Chen, J.-L., S.-F. Chen, and H.-C. Kuo. 2014. Clinical assessment and management of patients with National Institutes of Health categories IIIA and IIIB chronic prostatitis/chronic pelvic pain syndrome. Tzu Chi Medical Journal 26(4): 151–156.
Litwin, M.S., et al. 1999. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. The Journal of urology 162(2): 369–375.
Pontari, M.A., and M.R. Ruggieri. 2004. Mechanisms in prostatitis/chronic pelvic pain syndrome. The Journal of urology 172(3): 839–845.
Yang, X., et al. 2014. Multitargeted protective effect of Abacopteris penangiana against carrageenan-induced chronic prostatitis in rats. Journal of ethnopharmacology 151(1): 343–351.
Palapattu, G.S., et al. 2005. Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 26(7): 1170–1181.
Aruoma, O.I., et al. 1989. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radical Biology and Medicine 6(6): 593–597.
Kawada, N., et al. 1998. Effect of antioxidants, resveratrol, quercetin, and N‐acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology 27(5): 1265–1274.
Danilovic, A., et al. 2011. Protective effect of N-acetylcysteine on early outcomes of deceased renal transplantation. in Transplantation proceedings. Elsevier.
Cuzzocrea, S., et al. 2000. Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury. Cardiovascular research 47(3): 537–548.
Nitescu, N., et al. 2006. N-acetylcysteine attenuates kidney injury in rats subjected to renal ischaemia-reperfusion. Nephrology Dialysis Transplantation 21(5): 1240–1247.
Mahmoodi, M., et al. 2015. N-acetylcysteine improves function and follicular survival in mice ovarian grafts through inhibition of oxidative stress. Reproductive biomedicine online 30(1): 101–110.
Millea, P.J. 2009. N-acetylcysteine: multiple clinical applications. American family physician 80(3): 265–269.
Zafarullah, M., et al. 2003. Molecular mechanisms of N-acetylcysteine actions. Cellular and Molecular Life Sciences CMLS 60(1): 6–20.
Tepel, M., et al. 2003. The antioxidant acetylcysteine reduces cardiovascular events in patients with End-stage renal failure a randomized, controlled trial. Circulation 107(7): 992–995.
Meltzer, P.S. 2005. Cancer genomics: small RNAs with big impacts. Nature 435(7043): 745–746.
Wang, D., et al. 2010. Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets. PLoS One 5(9), e13067.
Ambs, S., et al. 2008. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer research 68(15): 6162–6170.
Liu, X., et al. 2012. Integrated sequence-structure motifs suffice to identify microRNA precursors. PloS one 7(3), e32797.
Tran, H., et al. 2013. Label-free and reagentless electrochemical detection of microRNAs using a conducting polymer nanostructured by carbon nanotubes: application to prostate cancer biomarker miR-141. Biosensors and Bioelectronics 49: 164–169.
Mitchell, P.S., et al. 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences 105(30): 10513–10518.
Eades, G., et al. 2011. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. Journal of Biological Chemistry 286(47): 40725–40733.
Van Jaarsveld, M., et al. 2013. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. Oncogene 32(36): 4284–4293.
Wei, J., et al. 2014. Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1–Nrf2, Tgfβ1/2, and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice. Free Radical Biology and Medicine 67: 91–102.
Chen, R., et al. 2011. In vivo study of four preparative extracts of Clematis terniflora DC. for antinociceptive activity and anti-inflammatory activity in rat model of carrageenan-induced chronic non-bacterial prostatitis. Journal of ethnopharmacology 134(3): 1018–1023.
Yu, Y., M.O. Fraser, and W.C. de Groat. 2004. Effects of ZD6169, a K ATP channel opener, on neurally-mediated plasma extravasation in the rat urinary bladder induced by chemical or electrical stimulation of nerves. Brain research 996(1): 41–46.
Kullisaar, T., et al. 2008. Oxidative stress in leucocytospermic prostatitis patients: preliminary results. Andrologia 40(3): 161–172.
Zhao, G., et al. 2013. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. Molecular cancer therapeutics 12(11): 2569–2580.
Acknowledgments
This work was supported by grant from the Special Project of Treatment Technology for Clinical Key Disease in Suzhou (LCZX201502).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Experimental protocols were performed in accordance with the European Community guidelines for the use and care of laboratory animals and approved by the Animal Ethical Committee of the First Affiliated Hospital of Soochow University, China.
Conflict of Interest
The authors declare that they have no conflicts of interest.
Additional information
Liang-Liang Wang and Yu-Hua Huang contributed equally to this work.
Rights and permissions
About this article
Cite this article
Wang, LL., Huang, YH., Yan, CY. et al. N-acetylcysteine Ameliorates Prostatitis via miR-141 Regulating Keap1/Nrf2 Signaling. Inflammation 39, 938–947 (2016). https://doi.org/10.1007/s10753-016-0327-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-016-0327-1